Campuses:

Precision medicine

Saturday, September 16, 2017 - 11:20am - 11:50am
Yi-Hsiang Hsu (Harvard Medical School)
The fast moving of the cancer immunotherapy field has generated tremendous excitement regarding new therapeutic strategies and will likely change the paradigm of therapeutic interventions for cancer. Neoantigens, generated by tumor-specific DNA alterations that result in the formation of novel protein sequences and only in cancer cells, represent an optimal target for the immune system and make possible a new class of highly personalized vaccines with the potential for significant efficacy with reduced side effects.
Thursday, September 14, 2017 - 2:00pm - 2:45pm
Eric Laber (North Carolina State University)
A treatment regime formalizes personalized medicine as a function from individual patient characteristics to a recommended treatment. A high-quality treatment regime can improve patient outcomes while reducing cost, resource consumption, and treatment burden. Thus, there is tremendous interest in estimating treatment regimes from observational and randomized studies. However, the development of treatment regimes for application in clinical practice requires the long-term, joint effort of statisticians and clinical scientists.
Thursday, September 14, 2017 - 4:30pm - 5:00pm
Lan Wang (University of Minnesota, Twin Cities)
Finding the optimal treatment regime (or a series of sequential treatment regimes) based on individual characteristics has important applications in areas such as precision medicine, government policies and active labor market interventions. In the current literature, the optimal treatment regime is usually defined as the one that maximizes the average benefit in the potential population. This paper studies a general framework for estimating the quantile-optimal treatment regime, which is of importance in many real-world applications.
Subscribe to RSS - Precision medicine